Myomo (MYO) Depreciation & Amortization (CF) (2016 - 2025)
Myomo's (MYO) quarterly Depreciation & Amortization (CF) came in at $246851.0 in Q3 2025, up 407.06% YoY from $48683.0 in Q3 2024, and up 29.38% on a QoQ basis from $190798.0 in Q2 2025.
Myomo (MYO) Depreciation & Amortization (CF) (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $246851.0 in Q3 2025.
- Quarterly Depreciation & Amortization (CF) rose 407.06% year-over-year to $246851.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $596091.0 (up 189.49% YoY) and the FY2024 annual result came in at $205910.0, up 25.32% from the prior year.
- Depreciation & Amortization (CF) climbed to $246851.0 in Q3 2025, from $190798.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $246851.0 in Q3 2025 to a low of $23313.0 in Q1 2021.
- A 5-year average of $68689.5 and a median of $48683.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) tumbled 43.15% — and 2025, when it jumped 433.74%.
- Tracing MYO's Depreciation & Amortization (CF) over 5 years: stood at $50757.0 in 2021, then dropped by 3.35% to $49057.0 in 2022, then plunged by 43.15% to $27890.0 in 2023, then jumped by 228.3% to $91564.0 in 2024, then jumped by 169.59% to $246851.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $246851.0 (Q3 2025), $190798.0 (Q2 2025), and $158442.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Myomo | 72.11 Mn | 53.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 246,851.00 |
| Sep 30, 2025 | 246,851.00 |
| Jun 30, 2025 | 190,798.00 |
| Jun 30, 2025 | 190,798.00 |
| Mar 31, 2025 | 158,442.00 |
| Mar 31, 2025 | 158,442.00 |
| Dec 31, 2024 | 91,564.00 |
| Dec 31, 2024 | 91,564.00 |
| Sep 30, 2024 | 48,683.00 |
| Sep 30, 2024 | 48,683.00 |
| Jun 30, 2024 | 35,978.00 |
| Jun 30, 2024 | 35,978.00 |
| Mar 31, 2024 | 29,685.00 |
| Mar 31, 2024 | 29,685.00 |
| Dec 31, 2023 | 27,890.00 |
| Dec 31, 2023 | 27,890.00 |
| Sep 30, 2023 | 35,794.00 |
| Sep 30, 2023 | 35,794.00 |
| Jun 30, 2023 | 51,990.00 |
| Jun 30, 2023 | 51,990.00 |